Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The Board of Directors in Brain+ A/S intends to execute a rights issue of units of approximately DKK 15.7 million in order to intensify commercial activities

COMPANY ANNOUNCEMENT Copenhagen, Denmark, March 29, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Today, the Board of Directors in Brain+ A/S (“Brain+” or the “Company”) has resolved to carry out a preferential rights

Notice of Annual General Meeting in Scandinavian Biogas Fuels International AB (PUBL)

The shareholders of Scandinavian Biogas Fuels International AB (publ), 556528-4733, (the “Company”) are hereby summoned to the annual general meeting (“AGM”) on Thursday 27 April 2023 at 14.00 at World Trade Center, Entrance D, Klarabergsviadukten 70, in Stockholm.             The Board of Directors has resolved that shareholders shall have the right to exercise their voting rights in advance through postal voting pursuant to Chapter 7 Section 4 a of the Companies Act (2005:551) and the Company’s Articles of Associations. Therefore, shareholders may choose to exercise their voting rights

BioStock: ExpreS2ion´s CEO on current development and the rights issue

ExpreS2ion Biotechnologies is eagerly awaiting top-line results from the phase III study with its Covid-19 vaccine. Meanwhile the cancer vaccine candidate ES2B-C001 is advancing towards the clinic. BioStock spoke to CEO Bent U. Frandsen to find out more about the development plans and the unit issue that will pave the way for further development.Read the full article at biostock.se : https://www.biostock.se/en/2023/03/expres2ions-ceo-on-current-development-and-the-rights-issue/ This is a press release from BioStock - Connecting Innovation & Capital. https:/

HANZA revises and expands sustainability goals

HANZA's Board of Directors has decided on a revised sustainability strategy with new and expanded sustainability goals. The goals are in line with the Paris Agreement and the UN's global goals for sustainable development and also include social responsibility and corporate governance.The revised sustainability strategy has been developed together with the company's overall strategy "HANZA 2025". Together with the financial goals, the sustainability goals will ensure that HANZA achieves long-term profitable and sustainable growth. Furthermore, HANZA's sustainability strategy means that

HC Andersen Capital Events 29/03: Meet the top management in NNIT & Pharma Equity Group

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.NNIT - Presentation of annual report 2022NNIT released its annual report on 23 March 2023. Meet NNIT’s management who will present the results followed by a Q&A session at a virtual live event.   In 2022, NNIT grew its topline on its continuing business by 10% and experienced better growth in the second half of 2022 with most of the growth driven by acquisitions. In 2022, NNIT realized an operating loss (EBIT) of DKK 7m, which is a level that

Biosergen provides Phase 2 clinical development strategy update

Stockholm, Sweden – March 29, 2023 – Biosergen AB (“Biosergen” or the “Company”), today announced an update of the Company’s Phase 2 clinical trial development strategy. Based on the data from the completed Phase I trial, showing no severe side effects associated with BSG005, Biosergen will initiate a Phase 2 trial to show BSG005’s potential to challenge Amphotericin B’s role as a last resort antifungal treatment, as well as to de-risk the further development path of BSG005.Biosergen is pleased to announce its plans to initiate its first Phase 2 clinical trial towards the end of Q2 2023.

Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January – 31 December 2022

Cline Scientific AB (publ) ("Cline" or the "Company") issues the following annual report for 2022.The report is published at www.clinescientific.com/financial-reports   The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8:30 CET on 29 March 2023.   For more information, please contact: Patrik Sundh, CEO Email: patrik.sundh@clinescientific.com Phone: +46 703-585 088   About Cline Scientific Cline Scientific develops

Valmet to retrofit the automation system at Alholmens Kraft’s biopower plant in Pietarsaari, Finland

Valmet Oyj’s trade press release March 29, 2023 at 9:30 a.m. EESTValmet will replace an existing third-party automation system with a Valmet DNA Automation System at Oy Alholmens Kraft Ab’s power plant unit AK1 in Pietarsaari, Finland. The delivery will be handed over to the customer in November 2023. The order was included in Valmet’s orders received of the fourth quarter 2022. The value of the order will not be disclosed.  “Our other power plant unit AK2, which is one of the world’s largest biomass-fired combined heat and power (CHP) plants, has been run reliably with the Valmet DNA

Eight new LNG carriers will feature Wärtsilä reliquefaction systems

Wärtsilä Corporation, Press release, 29 March 2023 at 9.30 AM EESTTechnology group Wärtsilä continues to strengthen its established position as a major supplier to the LNG carrier vessel sector. Following an earlier newbuild programme in June 2022 for four new vessels, the company has now been awarded the contract to supply reliquefaction systems  for a further eight ships. These eight vessels will be owned by various leading global shipping companies. The orders by Hudong Zhonghua Shipyard were booked into Wärtsilä’s order intake in Q1 2023. The selection of

The race for market shares intensifies as US operators move to MultiGigabit

To attract subscribers, an increasing number of US Telecom and fiber operators are offering MultiGigabit services (2 Gbps or more). To meet this trend, InCoax is introducing a new family of MultiGigabit Network Termination Equipment (NTE).The new InCoax A251 series, capable of 2.5 Gbps data rates to the individual subscriber, has a planned sales start in April 2023.According to the OMDIA 2022 report more than 25 US operators are currently offering MultiGigabit services. The MultiGigabit trend was introduced by Google Fiber two years ago, with an offering of 2/1 Gbps (down-/upstream)

Realheart's CEO to Present at the Swiss Nordic Bio Zürich Healthcare Investor Conference

Press Release, 29 March, 2023 Artificial hearts open the door to a paradigm shift in the care of patients with severe heart failure. Here, saving lives and reducing healthcare costs go hand in hand. There is an increased interest in the possibilities of total artificial hearts (TAH) and the interest in Realheart is much higher this year compared to last year's conference. Ina Laura Perkins will present the company at 12.00 on March 30, followed by several personal meetings with European medtech investors.For the second year in a row, Realheart is participating in Business Sweden's

Notice to Annual General Meeting of shareholders in Loomis AB

N.B. The below is an unofficial translation of the Swedish original, in case of any discrepancies between the Swedish original and the English translation the Swedish text shall prevail. The shareholders of Loomis AB, Reg. No 556620-8095 (“Loomis” or the “company”), are hereby invited to participate in the annual general meeting (the ”AGM”) to be held on Thursday May 4, 2023 at 5 p.m. CEST, in Grünewaldsalen at Stockholm Concert Hall, entrance Kungsgatan 43, Stockholm. Registration for the AGM begins at 4.30 p.m. CEST. A.               NOTICE OF ATTENDANCE A person who wishes to

Kongsberg Automotive is awarded contract worth EUR 30 million

Kongsberg Automotive’s (KA) Flow Control Systems business unit (FCS) has been awarded a contract worth EUR 30 million in estimated lifetime revenue for a variety of PTFE  lined hoses. KA is the exclusive supplier of PTFE line hose for a major North American industrial supplier in the semiconductor market. KA’s product will be incorporated into industrial processing industries, including semiconductors, chemical processing, and other fluid transfer systems. “We are pleased to report that this big win for FCS is of great strategic importance for KA.

STOREBRAND ASA – Initiating NOK 500 million Share Buyback Program today

The Board of Storebrand ASA ("the Board") has decided to continue the share buyback program today, 29 March 2023, with a tranche amounting to a maximum of NOK 500 million ("the program"). This is equivalent to approx. 1.4% of the share capital in Storebrand ASA given the last closing price of NOK 74.00. The program will end no later than 30 June 2023. In connection with the publication of Storebrand's 4th quarter 2022 results, Storebrand announced that it would seek approval from the Norwegian Financial Supervisory Authority (NFSA) for a NOK 500 million tranche. The approval was received

Implantica presents at Redeye Future of Healthcare Seminar

Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces that on Thursday, March 30, at 14:45, Peter Forsell presents Implantica and it’s latest developments at Redeye’s Future of Healthcare Seminar.The presentation will be live broadcasted in English and can be followed at: https://www.redeye.se/events/870753/redeye-future-of-healthcare-event where the replay and the presentation will be available afterwards. For further information, please contact: Nicole Pehrsson, Chief Corporate Affairs OfficerTelephone (CH): +41 (0)79

Notice to convene Annual General Meeting in Wirtek A/S

Company Announcement no. 3/202329 March 2023   Wirtek A/S (CVR-nr. 26042232) convenes the Annual General Meeting to be held completely electronically on Wednesday, 19 April 2023 at 15:00 (CET). Agenda according to articles of association: 1. The board of directors' report on the activities of the company during the past financial year 2. Adoption of the annual report 3. Resolution on distribution of profit or loss recorded in the annual report adopted by the general meeting 4. Resolution on discharge of the board of directors and executive board 5. Appointment of

Techstep signs new agreements worth NOK 2.1 million recurring revenue per year

Techstep has signed two new agreements to deliver SmartControl to a total of 4,400 employees in Norway.  SmartControl is a recurring Managed Service, where Techstep’s experts deliver best practice implementations, support, and proactive services. Techstep manage and secure the entire mobile eco-system of the customer’s enterprise, by combining Apple and Google Android knowledge and best in class software. This ensures that the customer’s devices and apps are always compliant, secure and up-to-date.   The first agreement is signed with a large company within the energy sector to

Notice of Annual General Meeting 2023

Oslo, 29 March 2023: The annual general meeting of Norwegian Energy Company ASA ("Noreco" or the "Company") will be held 25 April 2023 at 12:00 CEST. The general meeting will be held as a digital meeting only, with no physical attendance for shareholders. Information about log-in details for the meeting and all documents to be processed in the meeting are available in the attached Calling Notice and on the Company's website www.bluenord.com. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. *** Contact:

Publication of Annual Statement of Reserves and Resources

Oslo, 29 March 2023: Norwegian Energy Company ASA ("BlueNord" or the "Company") has today published its 2022 Annual Statement of Reserves and Resources. As of 31 December 2022, the Company’s net 2P (proven and probable) reserves and near-term 2C (contingent) resources were 220mmboe.  The Company's 2P reserves were 182.4mmboe at the end of 2022. This classification includes the Company’s producing Dan, Halfdan and Gorm hubs, the Tyra redevelopment project, the HCA gas lift project, four infill wells and the Valdemar Bo South development. The Company's near-term 2C resources, as

Publication of Annual Report for 2022

Oslo, 29 March 2023: Norwegian Energy Company ASA ("BlueNord" or the "Company") has today published the Annual Report for 2022. In addition, the Company's 2022 Annual Report in European Single Electronic Format (ESEF) is attached. The reports will be made available at the Company's website: www.bluenord.com. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. *** Contact: Cathrine F. Torgersen, EVP Investor Relations & ESGPhone: +47 915 28 501Email: cathrine.torgersen@bluenord.com

Ahlstrom’s Cristal® Transparent Packaging papers achieve SAFER™ Designation, helping brands demonstrate human and environmental safety

AHLSTROM OYJ PRESS RELEASE MARCH 29, 2023 at 9:00 AM EET  In the movement to create more eco-friendly packaging, brand owners are seeking additional assurances their suppliers are providing safe and sustainable solutions that meet both packaging and consumer demands. To exceed these expectations, Ahlstrom is pleased to announce Cristal® Transparent Packaging Papers have met ChemFORWARD’s rigorous evaluation of human and environmental criteria for safer alternatives through the organization’s SAFER™ program. Cristal® transparent papers are ideal alternatives to non-renewable materials,

Arctic Bioscience – Annual report 2022

Arctic Bioscience has today released its Annual Report 2022, including the Board of Directors report and financial statements. The report and annual accounts were approved by the Board of Directors after close of business on 28[th] of March 2023.The report is attached to this stock notice and is available on the company’s website. On Thursday 30 March 2023, at 12:00 CET, the Company will host a webcast to present the results an give an operational update. Following the presentation, it will be opened for questions from the audience. Webcast details: Date: Thursday 30 March 2023

Q2: Improved inventory levels and strengthened margin from the first quarter

Second quarter •     Net sales rose 2.2 per cent to SEK 6,272 million (6,137). •     Organic sales growth was -2.4 per cent (10.6), of which SMB accounted for -10.0 per cent (7.0) and LCP 1.1 per cent (15.7). •     The gross margin amounted to 14.6 per cent (14.7). •     Adjusted EBITA amounted to SEK 212 million (275), corresponding to an adjusted EBITA margin of 3.4 per cent (4.5). In the first quarter of 2022/23, the adjusted EBITA margin amounted to 3.0 per cent. •     EBIT totalled SEK 157 million (220), including items affecting comparability of SEK -9 million (-13).

MAG Interactive AB (publ) publishes Interim Report September – February 2022/2023

MAG reached its highest Q2 revenue yet; net sales increased 25% to 96 MSEK, and ARPDAU grew 32% compared to the same quarter last year.Summary of the period December 2022 – February 2023: · The Group's net sales for the period were 96 113 KSEK (76 772 KSEK), an increase of 25 % · EBITDA for the period was 9 826 KSEK (21 541 KSEK) · The Group's game contribution for the period was 42 944 KSEK (54 072 KSEK), a decrease of 21 % · Average revenue per daily active user (ARPDAU) for the period was 7,8 US cents (6,0 US cents), an increase of 32 % · The result per share during the

There are no items matching the current filter
There are no more items matching the current filter
Back to top